Inappropriate Shock Reduction wIth PARAD+ Rhythm DiScrimination (ISIS-ICD)
Sponsor: MicroPort CRM
This NA trial investigates Tachycardia and is currently completed. MicroPort CRM leads this study, which shows 10 recorded versions since 2011 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
10 versions recorded-
Sep 2025 — Present [monthly]
Completed NA
-
Sep 2024 — Sep 2025 [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Jan 2023 — Jul 2024 [monthly]
Completed NA
-
Dec 2022 — Jan 2023 [monthly]
Completed NA
▶ Show 5 earlier versions
-
Jan 2021 — Dec 2022 [monthly]
Completed NA
-
Apr 2019 — Jan 2021 [monthly]
Completed NA
-
Jun 2018 — Apr 2019 [monthly]
Completed NA
-
Mar 2018 — Jun 2018 [monthly]
Completed NA
Phase: PHASE4 → NA
-
Jan 2017 — Mar 2018 [monthly]
Completed PHASE4
First recorded
Oct 2011
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- MicroPort CRM
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
Alzira, Spain , Amiens, France , Anaheim, United States , Angers, France , Annecy, France , Avignon, France , Badalona, Spain , Bari, Italy , Basildon, United Kingdom , Blackpool, United Kingdom and 64 more locations